High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
High resolution melting analysis of KRAS, BRAF and PIK3CA in KRASexon 2 wild-type metastatic colorectal cancer ; volume:13 ; number:1 ; day:1 ; month:4 ; year:2013 ; pages:1-10 ; date:12.2013
BMC cancer ; 13, Heft 1 (1.4.2013), 1-10, 12.2013
- Creator
-
Guedes, Joana G.
- Contributor
-
Veiga, Isabel
Rocha, Patricia
Pinto, Pedro
Pinto, Carla
Pinheiro, Manuela
Peixoto, Ana
Fragoso, Maria
Raimundo, Ana
Ferreira, Paula
Machado, Manuela
Sousa, Nuno
Lopes, Paula
Araújo, António
Macedo, Joana
Alves, Fernando
Coutinho, Camila
Henrique, Rui
Santos, Lúcio L.
Teixeira, Manuel R.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-13-169
- URN
-
urn:nbn:de:1111-201603046574
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guedes, Joana G.
- Veiga, Isabel
- Rocha, Patricia
- Pinto, Pedro
- Pinto, Carla
- Pinheiro, Manuela
- Peixoto, Ana
- Fragoso, Maria
- Raimundo, Ana
- Ferreira, Paula
- Machado, Manuela
- Sousa, Nuno
- Lopes, Paula
- Araújo, António
- Macedo, Joana
- Alves, Fernando
- Coutinho, Camila
- Henrique, Rui
- Santos, Lúcio L.
- Teixeira, Manuel R.
- SpringerLink (Online service)
Other Objects (12)
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
Prävalenz und Heterogenität von KRAS, BRAF und PIK3CA Mutationen in kolorektalen Adenokarzinomen und ihren korrespondierenden Metastasen
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF V600 wild-type colorectal cancer
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
Clinical pharmacogenomic testing of KRAS, BRAF and EGFRmutations by high resolution melting analysis and ultra-deep pyrosequencing
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
Prävalenz und Heterogenität von KRAS, BRAF und PIK3CA Mutationen in kolorektalen Adenokarzinomen und ihren korrespondierenden Metastasen
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF V600 wild-type colorectal cancer
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
Clinical pharmacogenomic testing of KRAS, BRAF and EGFRmutations by high resolution melting analysis and ultra-deep pyrosequencing
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
Prävalenz und Heterogenität von KRAS, BRAF und PIK3CA Mutationen in kolorektalen Adenokarzinomen und ihren korrespondierenden Metastasen
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study
Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
A phospho-proteomic study of cetuximab resistance in KRAS/NRAS/BRAF V600 wild-type colorectal cancer
Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status
Clinical pharmacogenomic testing of KRAS, BRAF and EGFRmutations by high resolution melting analysis and ultra-deep pyrosequencing
A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer